People with sickle cell disease can now live longer with this new drug

Reportgist
1 Min Read
- Advertisement -

Voxelotor, also known as Oxbryta, is a drug produced by Pfizer that has the potential to significantly improve the lives of people suffering from this fatal genetic blood disorder.>>>CONTINUE FULL READING HERE....CONTINUE READING THE ARTICLE FROM THE SOURCE

Voxelotor works by helping red blood cells carry more oxygen by stabilising haemoglobin, the protein responsible for oxygen transport. It’s a pill that is taken daily. This can significantly reduce the frequency and severity of pain crises, improve overall health, and potentially lead to a longer lifespan.

Sickle cell disease causes red blood cells to become sickle-shaped, leading to early death and reduced oxygen delivery throughout the body. It also results in chronic anaemia, excruciating pain episodes (called crises), and a variety of complications like stroke, fatigue, delayed growth, and organ damage.

Voxelotor or oxbryta

- Advertisement -

While the drug was initially rejected by the United Kingdom’s NHS due to cost concerns, the National Institute for Health and Care Excellence (NICE) has finally approved it after a price negotiation. This means easier access to this potentially life-changing treatment for those who need it.

Although it’s not available in Nigeria currently, it’s only a matter of time before its arrival.>>>CONTINUE FULL READING HERE

- Advertisement -
READ:  2 Reasons Why You Should Not Shave Your Pubic Hair
- Advertisement -
Share This Article
error: Content is protected !!